Search
Now showing items 1-10 of 43
The Pattern of Entry of Generic Drugs into the Brazilian Pharmaceutical Market
(Sociedade Brasileira de Econometria, 2017)
Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012
(BMCPromoción y Prevención FarmacéuticaLondres, Inglaterra, 2022)
Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimusMonitorización terapéutico del tacrolimus en pacientes pediátricos trasplantados sujetos a conversión de marcas comerciales
(Sociedad Espanola de Farmacia Hospitalaria, 2017-03)
Objective: Therapeutic monitoring during interchange of tacrolimus commercial formulations is essential to ensure similar exposure in transplant patients. However, there are limited data in the pediatric transplant population. ...
Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection Model
(American Society for MicrobiologyGRIPE: Grupo Investigador de Problemas en Enfermedades InfecciosasWashington, Estados Unidos, 2022)
Acceptance of generic drugs by users from sector C, D and E sectors in three zones of LimaAceptación de medicamentos genéricos por usuarios de sectores C, D y E en tres zonas de Lima
(Universidad Nacional Mayor de San Marcos, Facultad de Farmacia y Bioquímica, 2012)
Pharmacokinetic evaluation of four ivermectin generic formulations in calves
(Elsevier Science, 2004-01)
The plasma concentration profiles of four randomly chosen ivermectin (IVM) generic formulations (IVM G1-G4) were compared after their subcutaneous (SC) administration to healthy calves. The disposition of other avermectin-type ...
Generic drugs: their economic importance in public health systems and the need for in vitro studies to establish their bioequivalenceMedicamentos genéricos: su importancia económica en los sistemas públicos de salud y la necesidad de estudios in vitro para establecer su bioequivalencia
(Universidad de Costa Rica, Sede de Occidente, 2017)
Efectividad y seguridad del esquema genérico Lamivudina/Zidovudina/Efavirenz en pacientes VIH (+). Estudio fase IV y comparación con el mismo esquema de medicamentos innovadoresEffectiveness and safety of generic Lamivudine/Zidovudine/Efavirenz in HIV (+) patients. Phase IV study and comparison with generic and innovator drugs
(Universidad de Antioquia, Facultad de Ciencias Farmacéuticas y AlimentariasPromoción y Prevención FarmacéuticaMedellín, Colombia, 2021)